Frier Levitt’s life sciences and pharmacy transactions group maintains a national practice focused on mergers and acquisitions, joint ventures, partnerships and affiliations involving pharmacies and pharmacy-related businesses. With deep regulatory acumen and a proven track record in pharmacy M&A, we structure and negotiate transactions that achieve our clients’ strategic goals while mitigating regulatory, payor, and operational risks.
Our attorneys advise clients on both the buy-side and sell-side of pharmacy and life sciences transactions, with particular emphasis on middle-market and lower-middle-market transactions involving independent retail pharmacies, specialty pharmacies, 503A and 503B compounding pharmacies, long-term care pharmacies, and home infusion pharmacies.
With a deep understanding of the life sciences regulatory environment, Frier Levitt structures transactions that align with each client’s strategic, financial, and operational objectives. Our team develops innovative strategies and transaction models designed to help clients achieve both short-term goals and long-term sustainability. We guide clients through mergers, acquisitions, and collaborative ventures that provide opportunities for realization of value, financial stability, economies of scale, enhanced management expertise, and access to new technologies.
Beyond providing end-to-end guidance and support for the transaction itself, Frier Levitt guides clients through post-closing compliance with regulatory and third-party payor requirements as well as contractual relationships that are aligned with the parties’ shared long-term vision for the business, supporting lasting success and compliance.
Who We Represent
Our Transactions Group represents a diverse group of providers and businesses, including:
- Retail pharmacies
- Specialty pharmacies
- Home infusion pharmacies
- 503A and 503B compounding pharmacies
- Long-term care pharmacies
- 340B contract pharmacies
- Entrepreneurs and other industry investors
Transactional Matters
Our attorneys routinely advise clients on a broad spectrum of transactional matters, including:
- Mergers and acquisitions (M&A)
- Private equity transactions
- Sales and acquisitions of assets, stock and other equity interests
- Joint ventures and strategic affiliations
- Executive and provider employment agreements
- Commercial real estate purchasing, selling and leasing arrangements
Our Services
Frier Levitt counsels clients throughout the entire lifecycle of a transaction, from early planning through post-closing integration, providing guidance on:
- Go-to-market strategies
- Deal structuring
- Buy-side and sell-side due diligence review
- Compliance with the Anti-Kickback Statute and Stark Law
- Navigating licensing and permit issues, including State Board of Pharmacy, DEA and FDA requirements
- Closing on institutional loans, including SBA loans, in connection with an acquisition
- Preparation and negotiation of front-end documents, including letters of intent, non-disclosure agreements and exclusivity agreements
- Drafting and negotiation of definitive transaction documents, including:
- Asset and equity purchase agreements
- Contribution, subscription, and redemption agreements
- Employment, professional services, and management services agreements
- Recruitment agreements
- Space and equipment leases and purchase and sale agreements
- Transition services agreements
Representative Matters
Our attorneys have served as transactional and regulatory counsel in numerous pharmacy and life sciences transactions, including:
- Served as transactional and regulatory counsel to the seller in connection with the $12,000,000 sale of a home infusion pharmacy.
- Served as transactional and regulatory counsel to the purchaser in connection with the $10,000,000 purchase and seller financing of a specialty pharmacy.
- Served as transactional and regulatory counsel to the purchaser in connection with a $1,500,000 SBA financed acquisition of a retail pharmacy.
- Served as transactional and regulatory counsel to a Federally Qualified Health Center in connection with contracting with, and leasing space in multiple locations to, a 340B contract pharmacy.
- Served as special transactional and regulatory counsel purchaser in connection with a $6,000,000 purchase of a multistate compounding pharmacy.
- Served as transactional and regulatory counsel to multistate pharmacy holding company in connection with multiple acquisitions of compounding pharmacies ranging in value from $500,000 to $800,000.
Why Frier Levitt
Frier Levitt combines transactional sophistication with regulatory depth – a critical advantage in the industry. Our attorneys are both skilled negotiators and regulatory advisors, ensuring that every transaction structure not only achieves your business goals but also withstands regulatory scrutiny.
Whether you are a private equity fund, investor, or organization seeking to expand, Frier Levitt offers the experience and insight to maximize value, mitigate risk, and drive success in today’s evolving healthcare and life sciences marketplace.
How Frier Levitt Can Help
Frier Levitt provides strategic, industry-focused legal counsel tailored to your needs. Contact our team today to learn how we can help you.
